Ibrahim Sayyid, MBBS

Ibrahim Sayyid practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Ibrahim Sayyid's NPI, 1427498781, was assigned on July 1, 2013. Ibrahim Sayyid holds West Virginia license 30626.

Ibrahim Sayyid's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Ibrahim Sayyid's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Ibrahim Sayyid is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Ibrahim Sayyid to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ibrahim Sayyid practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ibrahim Sayyid's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Ibrahim Sayyid's licenses on file in 3 states: West Virginia, New York and Pennsylvania.

CMS data shows 629 Medicare services from Ibrahim Sayyid across 8 procedure codes in 2024, for 272 Medicare patients. Medicare paid $47,236 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Ibrahim Sayyid in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ibrahim Sayyid's median patient age at 74, with 48% women.

In 2024, Ibrahim Sayyid wrote 309 Medicare Part D claims for 100 patients. 81% of them were for generic drugs. CMS names the drug for 182 of them, across 9 drugs with 11 or more claims each, at $9,510 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

Ibrahim Sayyid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Ibrahim Sayyid from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $24.